What Perceptive Advisors LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1224962 · Filed Nov 16, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| 10.6M |
| +26.9% |
| $307.7M |
| 5.4% |
SYRESpyre Therapeutics, Inc. | 3.3M | −24.0% | $292.1M | 5.1% |
| 1.4M | +40.0% | $269.6M | 4.7% |
CELCCelcuity Inc. | 3.2M | −0.5% | $252.9M | 4.4% |
RYTMRhythm Pharmaceuticals, Inc. | 2.5M | −2.1% | $241.1M | 4.2% |
ROIVRoivant Sciences Ltd. | 6.5M | −19.5% | $238.1M | 4.1% |
RLAYRelay Therapeutics, Inc. | 12.7M | −9.8% | $229.8M | 4% |
ASNDAscendis Pharma A/S | 971.5K | −16.5% | $221.3M | 3.9% |
TVTXTravere Therapeutics, Inc. | 3.5M | −5.6% | $208.6M | 3.6% |
FRNMFreenome, Inc. | 12.6M | New | $198.5M | 3.5% |
EWTXEdgewise Therapeutics, Inc. | 4.1M | −5.4% | $168M | 2.9% |
INBXInhibrx Biosciences, Inc. | 1.3M | −0.4% | $129.3M | 2.3% |
NRIXNurix Therapeutics, Inc. | 5.4M | +24.3% | $127.4M | 2.2% |
KARDKardigan, Inc. | 8.2M | ±0% | $121M | 2.1% |
MGTXMeiraGTx Holdings plc | 10.8M | ±0% | $118.7M | 2.1% |
PTGXProtagonist Therapeutics, Inc | 836.6K | −14.8% | $117.9M | 2.1% |
IMTXImmatics N.V. | 11.2M | +8.3% | $98.7M | 1.7% |
ZYMEZymeworks Inc. | 3.5M | −15.2% | $93.9M | 1.6% |
ORKAOruka Therapeutics, Inc. | 1.1M | −20.3% | $89.3M | 1.6% |
RVMDRevolution Medicines, Inc. | 433.1K | −17.9% | $88.9M | 1.5% |
SLDBSolid Biosciences Inc. | 11.9M | ±0% | $86.1M | 1.5% |
BCRXBiocryst Pharmaceuticals Inc | 10.3M | −0.1% | $85.8M | 1.5% |
AVLNAvalyn Pharma Inc. | 2.7M | ±0% | $76.2M | 1.3% |
TNGXTango Therapeutics, Inc. | 2.7M | −20.3% | $67.2M | 1.2% |
WATWaters Corp | 135K | New | $59.3M | 1% |
RGENRepligen Corp | 272.5K | +9.8% | $52.4M | 0.9% |
AORTArtivion, Inc. | 2.1M | +21.6% | $48.2M | 0.8% |
ANROAlto Neuroscience, Inc. | 1.8M | +9.4% | $45M | 0.8% |
IRDOpus Genetics, Inc. | 9M | New | $43.6M | 0.8% |
| 3M | New | $36.9M | 0.6% |
LKFTLakefront Biotherapeutics NV | 1.2M | New | $36.8M | 0.6% |
ABTAbbott Laboratories | 345.2K | New | $34.1M | 0.6% |
BLSMBlossomHill Therapeutics, Inc. | 1.8M | New | $33.8M | 0.6% |
SPDR SERIES TRUSTST STR SP BIOTPut option | 200K | −33.3% | $31.5M | 0.5% |
OBIOOrchestra BioMed Holdings, Inc. | 5M | −0.0% | $31.3M | 0.5% |
| 2.5M | +66.7% | $30.8M | 0.5% |
CRVSCorvus Pharmaceuticals, Inc. | 2.5M | −5.9% | $28.9M | 0.5% |
AVRAnteris Technologies Global Corp. | 3.4M | ±0% | $26.6M | 0.5% |
ANLAdlai Nortye Group Ltd. | 1.7M | −7.4% | $26.6M | 0.5% |
MMEDMiniMed Group, Inc. | 1.3M | New | $25.7M | 0.4% |
CTMXCytomX Therapeutics, Inc. | 9.3M | −11.2% | $25.2M | 0.4% |
RAPPRapport Therapeutics, Inc. | 724.3K | −6.3% | $24.3M | 0.4% |
SEPNSepterna, Inc. | 567.5K | New | $22.2M | 0.4% |
XFORX4 Pharmaceuticals, Inc | 7.4M | −7.3% | $21.3M | 0.4% |
ELVNEnliven Therapeutics, Inc. | 462.5K | New | $21.2M | 0.4% |
SABSSAB Biotherapeutics, Inc. | 6.6M | ±0% | $21M | 0.4% |
DYNDyne Therapeutics, Inc. | 1.3M | −52.9% | $20.4M | 0.4% |
EOLSEvolus, Inc. | 2.5M | ±0% | $19.7M | 0.3% |
YARWYarrow Bioscience, Inc. | 813.1K | New | $18.3M | 0.3% |
IMVTImmunovant, Inc. | 519.3K | −61.7% | $17.5M | 0.3% |
SCTXScribe Therapeutics, Inc. | 920.3K | New | $16.9M | 0.3% |
NAUTNautilus Biotechnology, Inc. | 11.6M | −0.6% | $16.4M | 0.3% |
STROSutro Biopharma, Inc. | 970.8K | −25.6% | $15.6M | 0.3% |
| 600K | +20.0% | $14.6M | 0.3% |
SRZNSurrozen, Inc. | 439.7K | −12.8% | $14.1M | 0.2% |
GRALGrail, Inc. | 96.9K | New | $13.6M | 0.2% |
DBVTDBV Technologies S.A. | 1.1M | −31.3% | $13.4M | 0.2% |
DHRDanaher Corp | 60K | −53.8% | $13.3M | 0.2% |
IRTCiRhythm Holdings, Inc. | 113.8K | −49.2% | $12.9M | 0.2% |
GHGuardant Health, Inc. | 70K | +69.4% | $12.5M | 0.2% |
IVVDInvivyd, Inc. | 13.8M | −25.6% | $12M | 0.2% |
ADPTAdaptive Biotechnologies Corp | 412.3K | −66.1% | $11.9M | 0.2% |
MANEVeradermics, Inc | 97K | New | $11.8M | 0.2% |
CELCUITY INCNOTE 2.750% 8/0 | 6.5M | ±0% | $11.7M | 0.2% |
AXGNAxogen, Inc. | 280K | +13.2% | $11.7M | 0.2% |
| 3.5M | +75.0% | $11.4M | 0.2% |
PALIPalisade Bio, Inc. | 8.4M | ±0% | $11.4M | 0.2% |
CBIOCrescent Biopharma, Inc. | 706.9K | +241.6% | $10.3M | 0.2% |
BBNXBeta Bionics, Inc. | 538.2K | −35.4% | $10.2M | 0.2% |
SPTXSeaport Therapeutics, Inc. | 500K | ±0% | $10.1M | 0.2% |
ENTXEntera Bio Ltd. | 3.4M | New | $10M | 0.2% |
MIRMMirum Pharmaceuticals, Inc. | 115.4K | ±0% | $9.9M | 0.2% |
QUREuniQure N.V. | 402.8K | +139.7% | $9.7M | 0.2% |
XERSXeris Biopharma Holdings, Inc. | 933.7K | +99.9% | $8.9M | 0.2% |
RACDResearch Alliance Corp IV | 700K | New | $8.3M | 0.1% |
CAPRCapricor Therapeutics, Inc. | 850K | New | $8M | 0.1% |
VRDNViridian Therapeutics, Inc.DE | 381.5K | −34.5% | $7.9M | 0.1% |
ABVXAbivax S.A. | 74K | ±0% | $7.3M | 0.1% |
ENGNenGene Therapeutics Inc. | 3.5M | −27.8% | $7M | 0.1% |
BLLNBillionToOne, Inc. | 65.2K | −24.9% | $6.9M | 0.1% |
AGMBAgomAb Therapeutics NV | 600K | ±0% | $6.7M | 0.1% |
LONALeonaBio, Inc. | 1.9M | ±0% | $6.6M | 0.1% |
BIIBBiogen Inc. | 28K | −89.9% | $6.3M | 0.1% |
DMRADamora Therapeutics, Inc. | 282.5K | New | $6M | 0.1% |
ADRXADARx Pharmaceuticals, Inc. | 300K | New | $6M | 0.1% |
NVCTNuvectis Pharma, Inc. | 240K | −76.0% | $5.1M | 0.1% |
OLMAOlema Oncology, Inc. | 575K | New | $5M | 0.1% |
OCSOculis Holding AG | 440.8K | −45.5% | $4.1M | 0.1% |
UNHUnitedHealth Group Inc | 10K | −91.4% | $3.7M | 0.1% |
MOBIMobia Medical, Inc. | 343.7K | −34.4% | $3.2M | 0.1% |
RVMDWRevolution Medicines, Inc. | 250K | ±0% | $2.9M | 0.1% |
| 200K | New | $2.7M | 0.1% |
OMOutset Medical, Inc. | 833.3K | ±0% | $2.5M | 0.1% |
CBLLCeribell, Inc. | 98.8K | New | $2.4M | 0.1% |
EDSAEdesa Biotech, Inc. | 563.2K | ±0% | $2.4M | 0.1% |
| 724.7K | New | $2.4M | 0.1% |
BRVEBraveheart Bio, Inc. | 115K | New | $2.3M | 0.1% |
OTLKOutlook Therapeutics, Inc. | 3.1M | ±0% | $1.8M | 0.1% |
ADGMAdagio Medical Holdings, Inc. | 9.9M | ±0% | $1.5M | 0.1% |
ADMAAdma Biologics, Inc. | 113.8K | ±0% | $1.1M | 0.1% |
KPRXKiora Pharmaceuticals Inc | 438.5K | ±0% | $1.1M | 0.1% |
MDLNMedline Inc. | 28K | ±0% | $971.6K | 0.1% |
XGNExagen Inc. | 114.9K | ±0% | $934.1K | 0.1% |
CNTBConnect Biopharma Holdings Ltd | 792.7K | ±0% | $872K | 0.1% |
SGMTSagimet Biosciences Inc. | 67.7K | New | $668.6K | 0.1% |
IBITiShares Bitcoin Trust ETF | 12K | New | $568.1K | 0.1% |
ENSCEnsysce Biosciences, Inc. | 86.7K | ±0% | $36K | 0.1% |